Neurocrine Bioscience buy Royal Bank of Canada
Start price
02.06.25
/
50%
€108.85
Target price
02.06.26
€127.53
Performance (%)
22.69%
Price
05.12.25
€133.55
Summary
This prediction is currently active. The prediction currently has a performance of 22.69%. This prediction currently runs until 02.06.26. The prediction end date can be changed by Royal_Bank_of_Canada at any time. Royal_Bank_of_Canada has 50% into this predictionPerformance without dividends (%)
| Name | 1w | 1m |
|---|---|---|
| Neurocrine Bioscience | 1.830% | 1.830% |
| iShares Core DAX® | 0.760% | -0.301% |
| iShares Nasdaq 100 | 0.732% | -1.001% |
| iShares Nikkei 225® | 1.025% | -3.621% |
| iShares S&P 500 | -0.036% | -0.194% |
Comments by Royal_Bank_of_Canada for this prediction
In the thread Neurocrine Bioscience diskutieren
Neurocrine Biosciences, Inc. (NASDAQ: NBIX) had its "outperform" rating re-affirmed by analysts at Royal Bank of Canada. They now have a $145.00 price target on the stock.
Ratings data for NBIX provided by MarketBeat
Stopped prediction by Royal_Bank_of_Canada for Neurocrine Bioscience
Neurocrine Bioscience
Start price
Target price
Perf. (%)
€117.85
29.10.25
29.10.25
€137.36
29.10.26
29.10.26
13.32%
05.12.25
05.12.25
Neurocrine Bioscience
Start price
Target price
Perf. (%)
€123.05
05.09.25
05.09.25
€127.74
05.09.26
05.09.26
8.53%
05.12.25
05.12.25
Neurocrine Bioscience
Start price
Target price
Perf. (%)
€112.45
31.07.25
31.07.25
€125.97
31.07.26
31.07.26
18.76%
05.12.25
05.12.25
Neurocrine Bioscience
Start price
Target price
Perf. (%)
€105.90
06.05.25
06.05.25
€128.38
06.05.26
06.05.26
26.11%
05.12.25
05.12.25
Neurocrine Bioscience
Start price
Target price
Perf. (%)
€83.38
14.04.25
14.04.25
€120.31
14.04.26
14.04.26
60.17%
05.12.25
05.12.25